✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

United Therapeutics Corp

Common Name
United Therapeutics
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,305
Ticker
UTHR
Exchange
NASDAQ/NGS
Description
United Therapeutics Corporation is a biotechnology company engaged in the development and commercialization of innovative pharmaceutical products. Primarily focusing on therapies to address unmet medi...

United Therapeutics's Financial Statements Preview

Below are the financial statements of United Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Total revenues
2,877.4a
2,327.5a
1,936.3a
Operating expenses
Cost of sales
-309.7a
-257.5a
-151.6a
Research and development
-481a
-408a
-322.9a
Selling, general, and administrative
-709.7a
-477.1a
-482.1a
Total operating expenses
-1,500.4a
-1,142.6a
-956.6a
Operating income
1,377a
1,184.9a
979.7a
Interest income
199.1a
162.7a
45.2a
Interest expense
-42.9a
-59.3a
-32.4a
Other income (expense), net
5.8a
-14a
-40.2a
Impairment of investment in privately-held company
0a
0a
-1.7a
Total other income (expense), net
162a
89.4a
-29.1a
Income before income taxes
1,539a
1,274.3a
950.6a
Income tax expense
-343.9a
-289.5a
-223.3a
Net income
1,195.1a
984.8a
727.3a
Limited Data Preview
You are viewing a limited preview of United Therapeutics’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind United Therapeutics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore United Therapeutics’s data sources below and access millions more through our Disclosure Search.

a. United Therapeutics's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?